With the support of the Ministry of Health and Welfare, China Medical University Hospital is actively promoting deeper collaboration and industrial development in healthcare between Taiwan, Malaysia, and beyond. Following the MOU signings with Laranang Medical Center and Borneo Medical Center in East Malaysia in March, the neurosurgery team led by Director Chun-Chung Chen returned to Malaysia, this time to Kuching. On the morning of May 13th, at the Pullman Hotel, they organized the 'Malaysia-Taiwan Smart Healthcare Forum for the Treatment of Brain Tumor,' inviting Malaysian healthcare professionals to participate. In the afternoon of the same day, a health lecture titled 'Unveiling Brain Cancer Cell Treatment and Regenerative Beauty' was held for the general public, aiming to raise awareness of health options and encourage medical check-ups and treatments in Taiwan.

The seminar and exhibition event, 'Malaysia-Taiwan Smart Healthcare Forum for the Treatment of Brain Tumor,' featured participation from Malaysian experts such as Dr. Albert Wong Sii Hieng, Director of Neurosurgery at the National Neurosurgery of Malaysia and Sarawak General Hospital, and Ms. Wu, Ling-Ying, Principal Assistant Director at the Taipei Economic and Cultural Office in Malaysia. Taiwan's healthcare companies, including Brain Navi Biotechnology with its automatic brain navigation robot, HIWIN Technologies Corp. with rehabilitation robots, Ubestream Inc. with AI voiceprint semantic recognition systems, Ever Supreme Bio Technology with cell therapy, Ever Fortune. AI with medical big data artificial intelligence, and Ever Young BioDimension with precision health medicine,

were also present to showcase and share their expertise, receiving enthusiastic responses from the Malaysian audience

Impressive Results in Immunotherapy and Stem Cell Regeneration Technology: 70% Tumor Control Rate in Cancer Cell Treatment

Director Chun-Chung Chen stated that cancer has long been one of the top ten leading causes of death in Taiwan, and cell therapy is a globally emerging treatment method that utilizes immune cells and stem cells to treat diseases such as cancer. China Medical University Hospital tailors the most suitable options based on different cancer types and patient conditions. The use of immune cells to suppress cancer cells, combined with standard treatment, has shown remarkable results with a tumor control rate (DCR) of over 70% in late-stage patients. Stem cell regenerative treatment techniques, including the use of autologous bone marrow stromal stem cell transplantation, have been applied to common conditions like degenerative arthritis and spinal cord injuries, significantly reducing joint pain and gradually restoring function. The goal is to share the latest brain cancer cell treatment technology and experiences with Malaysia.

Specializing in Complex Neurosurgery: A One-stop Caring Service Process for the Best International Patient Choice

China Medical University Hospital attracts an average of 33,000 international patients annually, with the number of Malaysian patients seeking treatment increasing steadily, reaching over 2,000 patients per year. During the afternoon health lecture, Director Chen Chun-Chung from the Neurosurgery Department presented 'Cell Therapy for Malignant Brain Tumors,' while Dr. Shyun-Jing Wee, a plastic surgeon of Malaysian nationality, discussed 'Smoothing Impressions - Wounds, Scars, and Regenerative Beauty.' CEO Aichi Chou of the International Center introduced 'China Medical University Hospital's Featured Medical Services and One-stop Medical Care.'

As the 'Sister Hospital of MD Anderson' in the United States and Taiwan's first medical center approved by the government for autologous immune cell therapy for all stages of cancer, China Medical University Hospital holds an innovative and leading position. It has received multiple awards, including the Taiwan International Medical Model Award, two individual awards, and two group awards, making it the most awarded single hospital. The hospital is also the first in Taiwan to be certified by the Chinese Muslim Association as a 'Muslim-friendly environment,' and in 2023, it won the 'Smart Hospital Initiative of the Year' at the Healthcare Asia Awards 2023. Recognized as the 'Best International Patient Specialty Center' and ' Best marketing initiative ' at the 2019 IMTJ International Medical Tourism Awards and receiving high praise as an ' Excellence in customer services' in 2020, China Medical University Hospital's international medical technology and services have been highly acclaimed, making it the best choice for international patients seeking medical treatment."